Cancer Immunology: Molecular Tools, New Therapeutic Targets, Challenges, and Opportunities
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 15 January 2026 | Viewed by 656
Special Issue Editor
Special Issue Information
Dear Colleagues,
We are pleased to announce the call for papers for a Special Issue entitled “Cancer Immunology: Molecular Tools, New Therapeutic Targets, Challenges, and Opportunities”. This Special Issue highlights the latest research and innovative approaches in cancer immunology. We welcome both original research articles and reviews, with topics of interest including the following:
- Mechanisms of tumor immune evasion;
- Drug repurposing to enhance the immune response;
- Immune checkpoints in cancer;
- Bioinformatics tools and flow cytometry to analyze the immune response in cancer;
- Cancer immunotherapy;
- Biomarkers of immunotherapy response;
- New therapeutic targets to modulate the immune response in cancer;
- Omics sciences in the study of immune responses;
- MicroRNA in the interactions between immune cells and tumor cells;
- Microbiome and its role in the immune response in cancer.
This Special Issue seeks to compile articles on advances in cancer immunology that highlight the most relevant findings and help improve the understanding of the interactions between immune cells and cancer cells.
Dr. Pablo C. Ortiz-Lazareno
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer immunology
- immune response
- immune evasion
- immune checkpoints
- immune response
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
